JN
John Newman Canaccord Genuity Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
20
Avg Return
Past Year
Past Year
7.3%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
95.2%
Neutral
4.8%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Technology
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Devices
Technology
Software - Infrastructure
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $18 |
121%
upside
| 1 | +0.25% |
0
%
| 6 Jan ‘26 2 days ago |
|
|
|
Buy
Maintained
| $25 |
45%
upside
| 3 | +53% |
0
%
| 19 Dec ‘25 20 days ago |
|
|
|
Buy
Maintained
| $130 |
104%
upside
| 2 | -16% |
0
%
| 8 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $1,057 |
30%
upside
| 5 | +8.1% |
0
%
| 4 Dec ‘25 1 month ago |
|
|
|
Buy
Initiated
| $10 |
91%
upside
| 1 | -0.38% |
0
%
| 3 Dec ‘25 1 month ago |
|
|
|
Buy
Initiated
| $126 |
23%
upside
| 1 | +7% |
0
%
| 12 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $21 |
102%
upside
| 1 | -9.2% |
0
%
| 21 Oct ‘25 2 months ago |
|
|
|
Hold
Downgraded
| $97 | – | 1 | – |
–
| 30 Sep ‘25 3 months ago |
|
|
|
Buy
Maintained
| $22 |
41%
upside
| 1 | -11% |
0
%
| 24 Sep ‘25 3 months ago |
|
|
|
Buy
Maintained
| $14 |
840%
upside
| 1 | -21% |
0
%
| 14 Mar ‘25 10 months ago |
|
|
|
Buy
Maintained
| $171.44 |
72%
upside
| 1 | -5.6% |
0
%
| 11 Mar ‘25 10 months ago |
|
|
|
Buy
Initiated
| $8 |
259%
upside
| 1 | +64% |
0
%
| 5 Mar ‘25 10 months ago |
|
|
|
Buy
Maintained
| $25 |
346%
upside
| 2 | -22% |
0
%
| 26 Feb ‘25 10 months ago |
|